These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34876193)

  • 21. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.
    Yandiola PPE; Capelastegui A; Quintana J; Diez R; Gorordo I; Bilbao A; Zalacain R; Menendez R; Torres A
    Chest; 2009 Jun; 135(6):1572-1579. PubMed ID: 19141524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study.
    Lazar Neto F; Marino LO; Torres A; Cilloniz C; Meirelles Marchini JF; Garcia de Alencar JC; Palomeque A; Albacar N; Brandão Neto RA; Souza HP; Ranzani OT; ; ; ;
    Clin Microbiol Infect; 2021 Jul; 27(7):1037.e1-1037.e8. PubMed ID: 33813111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.
    Yang Y; Xu F; Shi LY; Diao R; Cheng YS; Chen XY; Jing JY; Wang XD; Shen HH
    Chin Med J (Engl); 2012 Feb; 125(4):639-45. PubMed ID: 22490488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of β-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study.
    Ito A; Ishida T; Tachibana H; Nakanishi Y; Tokioka F; Yamazaki A; Washio Y; Irie H; Otake T
    J Infect Chemother; 2021 Oct; 27(10):1447-1453. PubMed ID: 34147355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a survival prediction model in elder patients with community-acquired pneumonia: a MIMIC-population-based study.
    Li N; Chu W
    BMC Pulm Med; 2023 Jan; 23(1):23. PubMed ID: 36650467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia.
    España PP; Capelastegui A; Quintana JM; Bilbao A; Diez R; Pascual S; Esteban C; Zalacaín R; Menendez R; Torres A
    J Infect; 2010 Feb; 60(2):106-13. PubMed ID: 19961875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low thoracic skeletal muscle is a risk factor for 6-month mortality of severe community-acquired pneumonia in older men in intensive care unit.
    Zhang M; Dong C; Jiang Y; Guo F; Cui K; Zhang S; Xu Y; Yang Y
    BMC Pulm Med; 2024 Aug; 24(1):387. PubMed ID: 39129026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital and long-term outcomes of ICU-treated severe community- and hospital-acquired, and ventilator-associated pneumonia patients.
    Karhu J; Ala-Kokko TI; Ylipalosaari P; Ohtonen P; Laurila JJ; Syrjälä H
    Acta Anaesthesiol Scand; 2011 Nov; 55(10):1254-60. PubMed ID: 22092131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in patients hospitalized with community-acquired aspiration pneumonia.
    Seo H; Cha SI; Lee WK; Park JE; Choi SH; Lee YH; Yoo SS; Lee SY; Lee J; Kim CH; Park JY
    J Infect Chemother; 2022 Jan; 28(1):47-53. PubMed ID: 34627705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
    Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
    Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe community-acquired pneumonia treated with β-lactam-respiratory quinolone vs. β-lactam-macrolide combination.
    Karhu J; Ala-Kokko TI; Ohtonen P; Syrjälä H
    Acta Anaesthesiol Scand; 2013 May; 57(5):587-93. PubMed ID: 23379766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction accuracy of commonly used pneumonia severity scores in Aboriginal patients with severe community-acquired pneumonia: a retrospective study.
    Tsai D; Secombe P; Chiong F; Ullah S; Lipman J; Hewagama S
    Intern Med J; 2023 Jan; 53(1):51-60. PubMed ID: 34524713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Severity scores for predicting clinically relevant outcomes for immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia].
    Saldías F; Díaz O
    Rev Chilena Infectol; 2011 Aug; 28(4):303-9. PubMed ID: 22052393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomogram for prediction of severe community-acquired pneumonia development in diabetic patients: a multicenter study.
    Tan R; Liu B; Zhao C; Yan J; Pan T; Zhou M; Qu H
    BMC Pulm Med; 2022 Nov; 22(1):403. PubMed ID: 36344933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Krebs von den Lungen-6 is associated with in-Hospital mortality of patients with severe Community-Acquired Pneumonia: A retrospective cohort study.
    Lu R; Yang H; Peng W; Tang H; Li Y; Lin F; Zhou A; Pan P
    Clin Chim Acta; 2023 Aug; 548():117524. PubMed ID: 37633319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors of mortality in severe community-acquired pneumonia: a model with data on the first 24h of ICU admission.
    Sirvent JM; Carmen de la Torre M; Lorencio C; Taché A; Ferri C; Garcia-Gil J; Torres A
    Med Intensiva; 2013; 37(5):308-15. PubMed ID: 23669439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality prediction using clinical and laboratory features in elderly patients with severe community-acquired pneumonia.
    Zhu Y; Zheng X; Huang K; Tan C; Li Y; Zhu W; Liu N; Zhou Y; Chen H; Li P; Cao Q; Chen M
    Ann Palliat Med; 2021 Oct; 10(10):10913-10921. PubMed ID: 34763453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Validation of a Risk Mortality Prediction Model for Patients with Pulmonary Tuberculosis Complicated by Severe Community-Acquired Pneumonia in the Intensive Care Unit.
    Cui K; Mao Y; Feng S; Luo H; Yang J; Bai L
    Infect Drug Resist; 2024; 17():3113-3124. PubMed ID: 39050825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Validation of a Nomogram for Predicting 28-Day Mortality on Admission in Elderly Patients with Severe Community-Acquired Pneumonia.
    Song Y; Wang X; Lang K; Wei T; Luo J; Song Y; Yang D
    J Inflamm Res; 2022; 15():4149-4158. PubMed ID: 35903289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.